Kenvue Shares Plunge 10% Following RFK Jr.’s Controversial Tylenol-Autism Claims: What Investors Need to Know
Kenvue Inc. Shares Plunge Amid Autism-Tylenol Controversy: What Investors Must Know Now Friday saw a sharp sell-off in Kenvue Inc. shares, tumbling over 10% following a bombshell report that Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is poised to link the widely used pain reliever Tylenol to autism risk in children born…